Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 48 of 55
Successful lung cancer drug trial boosts AstraZeneca
Drug giant said a phase III trial of Tagrisso had met its primary endpoint
FTSE 100 Index closes lower on mild profit taking
London's blue chips shed a couple of points at the close after gains earlier
Investments and investor services
FTSE 100 Index treads water as market awaits Carney comments
The Footsie fell 0.18 points to 6682.68 in early trading
London stocks close at 11-month highs after S&P500 hits new record
London shares closed on Monday at their highest level in exactly eleven months, feeding off Wall Street’s record levels
Footsie gains as traders eye possible interest rate cut
The FTSE 100 Index climbed 55.17 points while M&A talk involving AstraZeneca re-emerged
FTSE 100 closes above Brexit crisis levels
London’s FTSE 100 index on Wednesday closed above “Brexit” crisis levels for the first time since the morning of the In-Out European Union referendum polling last Thursday
Archive
Brokers pick their winners post-Brexit
Broadcaster ITV was downgraded, as was airline group IAG
Investments and investor services
BREXIT LIVE: City reaction as Britons choose leave
That's it from us for a very volatile Friday, more Brexit reaction to follow on Monday.
AstraZeneca to take impairment after US recommends against flu vaccine
Astra said its findings differed from those of the US CDC
AstraZeneca does US$770mln anaesthetic deal
British drug group said Aspen will acquire commercialisation rights to its anaesthetic medicines outside the US
Ireland-focused oil firms boosted as FTSE 100 Index rises
The FTSE 100 Index closed 24.02 points up at 6209.63
AstraZeneca bags US rights for gout-related drug
British drug group acquires exclusive US rights to Zurampic
Archive
FDA's ZS-9 ruling just a "bump in the road" for AstraZeneca
News from drugs giant Astra this morning was like the proverbial curate’s egg: good in parts.
AstraZeneca drug fails gastric cancer trial
Drug company says Lynparza fell short of hopes in phase three trial
Archive
No jumps on the way for William Hill, says Canaccord
Bookmaker William Hill has its target lowered by City broker Canaccord.....
FTSE 100 retreats late as miners suffer, small caps steady
Shares in London fall back late on despite solid start
Archive
Brokers: RBS downgrade as UBS frets over payout potential
Also, Tullow Oil, Astra Zeneca, Next, Armadale Capital, Eland Oil...
AstraZeneca to cut costs but stays silent on M&A talk
UK drug giant set to focus on cancer drugs but declines to comment on Medivation takeover speculation